Loewi is a technology company.
Loewi has raised $1.0M across 1 funding round.
Loewi has raised $1.0M in total across 1 funding round.
Loewi has raised $1.0M in total across 1 funding round.
Loewi's investors include Antler, btov Partners, Satgana.
LOEWI GmbH is a health tech startup that develops personalized nutrition and health solutions by analyzing user health data to deliver tailored nutrient recommendations and supplements.[1][3][4] As a scientific spin-off from TU München, it serves consumers and patients seeking optimized health, solving the problem of one-size-fits-all nutrition through its patented algorithm and Class I medical software Health Profile.[1][4] The company has secured early investment from High-Tech Gründerfonds since 2020, indicating solid growth momentum in the personalized health space based in Bavaria.[1]
LOEWI emerged as a spin-off from the Technical University of Munich (TU München), leveraging scientific expertise to bridge gaps in personalized medicine.[1] Its founding idea stemmed from combining blood diagnostics, lifestyle data, and advanced algorithms to create precise nutrient therapies, addressing the limitations of generic supplements.[1][4] Early traction came via investment from High-Tech Gründerfonds in 2020, marking a pivotal moment that fueled development of its core Health Profile technology.[1] Note that the company has since exited the fund's portfolio, signaling maturation or acquisition.[1]
LOEWI rides the wave of precision health and personalized medicine, a trend accelerated by advances in AI-driven data analysis and at-home diagnostics.[1][3] Its timing aligns with rising consumer demand for tailored wellness amid growing awareness of genetic and lifestyle factors in health, bolstered by market forces like expanded direct-to-consumer testing and regulatory support for digital health tools.[4] By democratizing personalized nutrition, LOEWI influences the ecosystem, pushing incumbents toward data personalization and fostering innovation in Europe's health tech startup scene, particularly in Germany.[1]
LOEWI is poised for expansion in the booming personalized nutrition market, potentially through partnerships with telehealth platforms or larger pharma players given its exit status and medical credentials.[1] Trends like AI-enhanced wearables and global health data interoperability will amplify its algorithm's impact, evolving its role from startup to scalable health platform. As precision health scales, LOEWI's mission to make optimal wellness universal could redefine consumer nutrition, building on its scientific origins to lead accessible, data-driven health transformation.[3]
Loewi has raised $1.0M across 1 funding round. Most recently, it raised $1.0M Seed in May 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2023 | $1.0M Seed | Antler, btov Partners, Satgana |